While there was no significant change seen in the MS patients, TAAR1 levels were significantly higher in the NIND patients than the healthy controls (Kruskal–Wallis Test; p = 0.0284, F = 4.284 with Dunn’s post-hoc multiple comparison test; * p = 0.0168 for NIND vs. Controls, p = 0.4130 for MS vs. Controls). The gene discussed is TAAR1; the disease is myeloid sarcoma.